Drugs elevating extracellular adenosine enhance cell cycling of hematopoietic progenitor cells as inferred from the cytotoxic effects of 5-fluorouracil

Experimental Hematology

Volumn 29, Issue 5, 2001, Pages 557-562

  Pospíšil, Milan ^a   Hofer, Michal ^a   Vacek, Antonín ^a   Netíková, Jaromíra ^a   Holá, Jiřina ^a   Znojil, Vladimír ^b   Weiterová, Lenka ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; DIPYRIDAMOLE; FLUOROURACIL;

ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE S PHASE; CELL LEVEL; CONTROLLED STUDY; DRUG CYTOTOXICITY; HEMATOPOIESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SIGNAL TRANSDUCTION; STEM CELL; SURVIVAL RATE;

ADENOSINE; ADENOSINE MONOPHOSPHATE; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW DISEASES; CELL CYCLE; COLONY-FORMING UNITS ASSAY; DIPYRIDAMOLE; DRUG SYNERGISM; EXTRACELLULAR SPACE; FLUOROURACIL; HEMATOPOIETIC STEM CELLS; MALE; MICE; PRODRUGS; RECEPTORS, PURINERGIC P1;

EID: 0343831987     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00622-1     Document Type: Article

References (37)

1. Abbracchio M.P., Burnstock G. Purinergic signalling. pathophysiological roles Jpn J Pharmacol. 78:1998;113.
2. Poulsen S.-A., Quinn R.J. Adenosine receptors. new opportunities for future drugs Bioorg Med Chem. 6:1998;619.
3. Rozengurt E. Adenosine receptor activation in quiescent Swiss 3T3 cells. Enhancement of cAMP levels, DNA synthesis and cell division. Exp Cell Res. 139:1982;71.
4. Rathbone M.P., Middlemiss P.J., Gysbers J.W., DeForge S., Costello P., Del Maestro R.F. Purine nucleosides and nucleotides stimulate proliferation of a wide range of cell types. In Vitro Cell Dev Biol. 28A:1992;529.
5. Abbracchio M.P. P1 and P2 receptors in cell growth and differentiation. Drug Dev Res. 39:1996;393.
6. Gualtieri R.J., Berne R.M., McGrath H.E., Huster W.J. Effect of adenine nucleotides on granulopoiesis and lithium-induced granulocytosis in long-term bone marrow cultures. Exp Hematol. 14:1986;689.
7. Pospíšil M., Hofer M., Netíková J., Viklická Š., Pipalová I., Bartoníčková A. Effect of dipyridamole and adenosine monophosphate on cell proliferation in the hemopoietic tissue of normal and γ-irradiated mice. Experientia. 48:1992;253.
8. Pospíšil M., Hofer M., Netíková J.et al. Elevation of extracellular adenosine induces radioprotective effects in mice. Radiat Res. 134:1993;323.
9. Pospíšil M., Hofer M., Znojil V., Vácha J., Netíková J., Holá J. Radioprotection of mouse hemopoiesis by dipyridamole and adenosine monophosphate in fractionated treatment. Radiat Res. 142:1995;16.
10. Pospíšil M., Hofer M., Znojil V., Vácha J., Netíková J., Holá J. Synergistic effect of granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on neutrophil production in mice. Blood. 86:1995;3692.
11. Pospíšil M., Hofer M., Znojil V.et al. Granulocyte colony-stimulating factor and drugs elevating extracellular adenosine synergize to enhance haematopoietic reconstitution in irradiated mice. Eur J Haematol. 60:1998;172.
12. Hofer M., Pospíšil M., Netíková J., Znojil V., Vácha J. Enhancement of haemopoietic spleen colony formation by drugs elevating extracellular adenosine. effects of repeated in vivo treatment Physiol Res. 46:1997;285.
13. Hofer M., Pospíšil M., Netíková J., Znojil V., Vácha J. Granulocyte colony-stimulating factor and drugs elevating extracellular adenosine act additively to enhance the hemopoietic spleen colony formation in irradiated mice. Physiol Res. 48:1999;37.
14. Marsh JC (1976) The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review. Cancer Res 36:1853.
15. Molineux G., Migdalska A., Haley J., Evans G.S., Dexter T.M. Total marrow failure induced by pegylated stem-cell factor administered before 5-fluorouracil. Blood. 83:1994;3491.
16. Jin L., Neff T., Blau C.A. Marrow sensitization to 5-fluorouracil using the ligands for Flt-3 and c-Kit. Exp Hematol. 27:1999;520.
17. Neta R., Keller J.R., Ali N., Blanchette F., Dubois C.M. Contrasting mechanisms of the myeloprotective effects of interleukin-1 against ionizing radiation and cytotoxic 5-fluorouracil. Radiat Res. 145:1996;624.
18. Plagemann P.G.W., Wohlhueter R.M., Woffendin C. Nucleoside and nucleobase transport in animal cells. Biochim Biophys Acta. 947:1988;405.
19. Gordon E.L., Pearson J.D., Dickinson E.S., Moreau D., Slakey L.L. The hydrolysis of extracellular adenine nucleotides by arterial smooth muscle cells. Regulation of adenosine production at the cell surface. J Biol Chem. 264:1989;18986.
20. Till J.E., McCulloch E.A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 14:1961;216.
21. Heyworth C.M., Spooncer E. In vitro clonal assays for murine multipotential and lineage restricted myeloid progenitor cells. Testa N.G., Molineaux G. Haemopoiesis. A practical approach. 1993;37 Oxford University Press, New York.
22. Fox M., Boyle J.M., Kinsella A.R. Nucleoside salvage and resistance to antimetabolite anticancer agents. Br J Cancer. 64:1991;428.
23. Allay J.A., Spencer H.T., Wilkinson S.L., Belt J.A., Blakley R.L., Sorrentino B.P. Sensitization of hematopoietic stem and progenitor cells to trimetrexate using nucleoside transport inhibitors. Blood. 90:1997;3546.
24. Mackey J.R., Baldwin S.A., Young J.D., Cass C.E. Nucleoside transport and its significance for anticancer drug resistance. Drug Resist Update I: 310:1998.
25. Chadwick M., Rogers W.I. The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia. Cancer Res. 32:1972;1045.
26. Tatsuta T., Shimizu K., Nishimura T., Suzuki H. Enhancement of activities of anti-tumor drugs by dipyridamole against multidrug-resistant human hepatoma LPC/PRF/5 cells. Anti-Cancer Drug Des. 6:1991;179.
27. Möser G.H., Schrader J., Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol. 256:1989;C799.
28. Nečas E, Šefc L, Šulc K, Barthel E, Seidel H-J (1998) Estimation of extent of cell death in different stages of normal hematopoiesis. Stem Cells 16:107.
29. Schoeffter P., Lugnier C., Demesy-Waeldele F., Stoclet J.C. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors. Biochem Pharmacol. 36:1987;3965.
30. Byron J.W. Drug receptors and the haemopoietic stem cells. Nature New Biol. 241:1973;152.
31. Nečas E., Poňka P., Neuwirt J. Study on the proliferative state of haemopoietic stem cells (CFU). Cell Tissue Kinet. 9:1976;223.
32. 2 as stimulator of haemopoietic stem cell proliferation. Nature. 247:1974;550.
33. Brown J.E., Adamson J.W. Modulation of in vitro erythropoiesis. Enhancement of erythroid colony growth by cyclic nucleotides Cell Tissue Kinet. 10:1977;289.
34. Morley A., Quesenberry P., Garrity M., Stohlman F. Inhibition of marrow growth by cyclic AMP. Proc Soc Exp Biol Med. 138:1971;57.
35. Kurland J.I., Hadden J.W., Moore M.A.S. Role of cyclic nucleotides in the proliferation of committed granulocyte-macrophage progenitor cells. Cancer Res. 37:1977;4534.
36. Kurtz A. Adenosine stimulates guanylate cyclase activity in vascular smooth muscle cells. J Biol Chem. 262:1987;6296.
37. Zidek Z. Adenosine - cyclic AMP pathways and cytokine expression. Eur Cytokine Netw. 10:1999;319.